Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Clonal landscape and clinical outcomes of telomere biology disorders: somatic rescue and cancer mutations

Blood (2024) 144 (23): 2402–2416.

https://doi.org/10.1182/blood.2024025023

Published: 2024

Includes: Supplemental data

Journal Articles

Critical Care Support in Infants Post-Allogeneic HCT: Large Single-Center Cohort Experience

Fabiana Cacace, Shaikha Alqahtani, Taylor McMichael, Carmem Bonfim, Andrea Bauchat, Timothy A. Driscoll, Paul L. Martin, Joanne Kurtzberg, Kris Michael Mahadeo

Blood (2024) 144 (Supplement 1): 374.

https://doi.org/10.1182/blood-2024-212041

Published: 2024

Journal Articles

Cultured Thymus Tissue Implantation for Congenital Athymia Post FDA Approval: Auto-Immunity and Novel Genetic Mutations

Shaikha Alqahtani, Fabiana Cacace, Taylor McMichael, Emily Dodd, Elizabeth McCarthy, Andrea Bauchat, Timothy A. Driscoll, Paul L. Martin, Carmem Bonfim, John Sleasman, Kris Michael Mahadeo

Blood (2024) 144 (Supplement 1): 1158.

https://doi.org/10.1182/blood-2024-211756

Published: 2024

Journal Articles

Interleukin-1 blockade in patients with Wiskott-Aldrich syndrome: a retrospective multinational case series

Blood (2024) 144 (16): 1699–1704.

https://doi.org/10.1182/blood.2024024524

Published: 2024

Includes: Supplemental data

Journal Articles

Outcomes of HLA-mismatched HSCT with TCRαβ/CD19 depletion or post-HSCT cyclophosphamide for inborn errors of immunity

Blood (2024) 144 (5): 565–580.

https://doi.org/10.1182/blood.2024024038

Published: 2024

Includes: Supplemental data

Journal Articles

An international learning collaborative phase 2 trial for haploidentical bone marrow transplant in sickle cell disease

Blood (2024) 143 (25): 2654–2665.

https://doi.org/10.1182/blood.2023023301

Published: 2024

Includes: Supplemental data

Journal Articles

Differential diagnosis of bone marrow failure syndromes guided by machine learning

Blood (2023) 141 (17): 2100–2113.

https://doi.org/10.1182/blood.2022017518

Published: 2023

Includes: Supplemental data

Journal Articles

Outcomes of Non-Myeloablative HLA-Haploidentical Bone Marrow Transplant with Thiotepa and Post-Transplant Cyclophosphamide in Children and Adults with Sickle Cell Disease, a Phase II Trial: Vanderbilt Global Haploidentical Transplant Learning Collaborative (VGC 2 )

Blood (2022) 140 (Supplement 1): 2383–2385.

https://doi.org/10.1182/blood-2022-165229

Published: 2022

Journal Articles

Early Donor T-Cell Engraftment Is Critical for Immune Tolerance in Reduced Intensity Haploidentical Bone Marrow Transplant with Post-Transplant Cyclophosphamide for Sickle Cell Disease: Vanderbilt Global Haploidentical Transplant Learning Collaborative (VGC 2 )

Blood (2022) 140 (Supplement 1): 10462–10464.

https://doi.org/10.1182/blood-2022-170552

Published: 2022

Journal Articles

Clinical, Immunological Features, Treatments, and Outcomes of Autoimmune Hemolytic Anemia in Patients with RAG Deficiency

Blood (2022) 140 (Supplement 1): 2448–2450.

https://doi.org/10.1182/blood-2022-162845

Published: 2022

Journal Articles

Excelent Option Therapy of BONE Marrow Failure in Fanconi Anemia Patients Withouth Full Match Donnor

Lisandro L Ribeiro, MD, Samantha Nichele, MD, marco Antonio Bitencourt, MD, Ricardo Petterle, Gisele Loth, MD, Daniela Pilonetto, Carmem Bonfim, MD

Blood (2016) 128 (22): 5075.

https://doi.org/10.1182/blood.V128.22.5075.5075

Published: 2016

Journal Articles

HCT Outcome in Patients with Fanconi Anemia Transplanted at Adult Age

Blood (2016) 128 (22): 4691.

https://doi.org/10.1182/blood.V128.22.4691.4691

Published: 2016

Journal Articles

Role of Donor Source on Clinical Outcomes and Inpatient Resource Utilization for Hematopoietic Cell Transplantation in Children with Acute Leukemia

Staci D Arnold, MD MBA, Ruta Brazauskas, PhD, Naya He, MPH, Yimei Li, PhD, Prakash Satwani, MD MBBS, Michael A Pulsipher, MD, Matt Hall, PhD, Yoshiko Atsuta, MD PhD, Jignesh D Dalal, MD, Theresa Hahn, PhD, Carmem Bonfim, MD, Nandita Khera, MD, Richard Aplenc, MD PhD, Wael Saber, MD MS

Blood (2016) 128 (22): 3575.

https://doi.org/10.1182/blood.V128.22.3575.3575

Published: 2016

Journal Articles

Inferior Access to Allogeneic Transplant in Disadvantaged Populations: A CIBMTR Analysis

Kristjan Paulson, MD, Ruta Brazauskas, PhD, Naya He, MPH, David Szwajcer, MD, Matthew D. Seftel, MBChB, FRCP(C), MRCP, Yoshiko Atsuta, MD PhD, Jignesh D Dalal, MD, Theresa Hahn, PhD, Carmem Bonfim, MD, Nandita Khera, MD, Linda J. Burns, MD, Lih-Wen Mau, PhD MPH, Navneet S. Majhail, MD, Wael Saber, MD MS

Blood (2016) 128 (22): 842.

https://doi.org/10.1182/blood.V128.22.842.842

Published: 2016

Journal Articles

The Impact of Pre-Transplant Depression on Outcomes of Allogeneic and Autologous Hematopoietic Stem Cell Transplantation

Areej El-Jawahri, MD, Yi-Bin Chen, MD, Ruta Brazauskas, PhD, Naya He, PhD, Stephanie J. Lee, MD MPH, Jennifer M Knight, MD, Theresa Hahn, PhD, Nandita Khera, MD, Jignesh D Dalal, MD, Carmem Bonfim, MD, Yoshiko Atsuta, MDPhD, Wael Saber, MD MS

Blood (2015) 126 (23): 265.

https://doi.org/10.1182/blood.V126.23.265.265

Published: 2015

Journal Articles

Analysis of risk factors influencing outcomes after cord blood transplantation in children with juvenile myelomonocytic leukemia: a EUROCORD, EBMT, EWOG-MDS, CIBMTR study

Blood (2013) 122 (12): 2135–2141.

https://doi.org/10.1182/blood-2013-03-491589

Published: 2013

Journal Articles

Long Term Follow up After Hematopoietic Stem Cell Transplantation for Fanconi Anemia: Analysis of 126 Pts Surviving More Than 2 Years After Transplant.

Carmem Bonfim, MD, Lisandro L Ribeiro, MD, Marco Bitencourt, Gisele Loth, MD, Daniela Pilonetto, Neiva Magdalena, MD, PhD, Mariester Malvezzi, Ricardo Pasquini, MD, PhD

Blood (2012) 120 (21): 3079.

https://doi.org/10.1182/blood.V120.21.3079.3079

Published: 2012

Journal Articles

Transplantation in patients with SCID: mismatched related stem cells or unrelated cord blood?

Blood (2012) 119 (12): 2949–2955.

https://doi.org/10.1182/blood-2011-06-363572

Published: 2012

Includes: Supplemental data

Journal Articles

Results of Allogeneic Hematopoietic Cell Transplantation in Persons with Fanconi Anemia and Pretransplant Cytogenetic Abnormalities, Myelodysplastic Syndrome, or Acute Leukemia

Mouhab Ayas, Jennifer Le-Rademacher, PhD, H. Joachim Deeg, M.D., Robert Peter Gale, MD, PhD, DSc, Stella M. Davies, MBBS, PhD, Rajinder PS Bajwa, MBBS, MD, MRCP, Minoo Battiwalla, MD, MS, Shimon Slavin, MD, Bruce Camitta, MD, Marc B Bierings, MD, PhD, Richard E. Harris, MD, Richard Olsson, MD PhD MMSc, Baldeep Wirk, MD, Biju George, MD, Carmem Bonfim, MD, Wael Saber, MD, MS

Blood (2011) 118 (21): 838.

https://doi.org/10.1182/blood.V118.21.838.838

Published: 2011

Journal Articles

Allogeneic Stem Cell Transplantation for Sickle Cell Disease in Brazil: The Time Is Now!

Belinda Pinto Simoes, MD, PhD, George B Navarro, MD, Fabiano Pieroni, MD, PhD, Luiz G Darrigo, Jr., MD, Daniela Moraes, MD, Ana Beatriz PL Stracieri, MD, PhD, Juliana F Fernandes, MD, Carmem Bonfim, MD, Gustavo Machado Teixeira, MD, Francisco J P Aranha, M.D., P.h.D., Júlio C. Voltarelli, MD, PhD

Blood (2011) 118 (21): 1064.

https://doi.org/10.1182/blood.V118.21.1064.1064

Published: 2011

NARROW

Clonal landscape and clinical outcomes of telomere biology disorders: somatic rescue and cancer mutations

Critical Care Support in Infants Post-Allogeneic HCT: Large Single-Center Cohort Experience

Cultured Thymus Tissue Implantation for Congenital Athymia Post FDA Approval: Auto-Immunity and Novel Genetic Mutations

Interleukin-1 blockade in patients with Wiskott-Aldrich syndrome: a retrospective multinational case series

Outcomes of HLA-mismatched HSCT with TCRαβ/CD19 depletion or post-HSCT cyclophosphamide for inborn errors of immunity

An international learning collaborative phase 2 trial for haploidentical bone marrow transplant in sickle cell disease

Differential diagnosis of bone marrow failure syndromes guided by machine learning

Outcomes of Non-Myeloablative HLA-Haploidentical Bone Marrow Transplant with Thiotepa and Post-Transplant Cyclophosphamide in Children and Adults with Sickle Cell Disease, a Phase II Trial: Vanderbilt Global Haploidentical Transplant Learning Collaborative (VGC 2 )

Early Donor T-Cell Engraftment Is Critical for Immune Tolerance in Reduced Intensity Haploidentical Bone Marrow Transplant with Post-Transplant Cyclophosphamide for Sickle Cell Disease: Vanderbilt Global Haploidentical Transplant Learning Collaborative (VGC 2 )

Clinical, Immunological Features, Treatments, and Outcomes of Autoimmune Hemolytic Anemia in Patients with RAG Deficiency

Excelent Option Therapy of BONE Marrow Failure in Fanconi Anemia Patients Withouth Full Match Donnor

HCT Outcome in Patients with Fanconi Anemia Transplanted at Adult Age

Role of Donor Source on Clinical Outcomes and Inpatient Resource Utilization for Hematopoietic Cell Transplantation in Children with Acute Leukemia

Inferior Access to Allogeneic Transplant in Disadvantaged Populations: A CIBMTR Analysis

The Impact of Pre-Transplant Depression on Outcomes of Allogeneic and Autologous Hematopoietic Stem Cell Transplantation

Analysis of risk factors influencing outcomes after cord blood transplantation in children with juvenile myelomonocytic leukemia: a EUROCORD, EBMT, EWOG-MDS, CIBMTR study

Long Term Follow up After Hematopoietic Stem Cell Transplantation for Fanconi Anemia: Analysis of 126 Pts Surviving More Than 2 Years After Transplant.

Transplantation in patients with SCID: mismatched related stem cells or unrelated cord blood?

Results of Allogeneic Hematopoietic Cell Transplantation in Persons with Fanconi Anemia and Pretransplant Cytogenetic Abnormalities, Myelodysplastic Syndrome, or Acute Leukemia

Allogeneic Stem Cell Transplantation for Sickle Cell Disease in Brazil: The Time Is Now!

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only